Stock value for Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) fell nearly 10 percent Wednesday after the company announced a net loss for the three months that ended in September that was nearly twice as much as analysts expected.
Content Item Type:
News [1]
Summary:
Stock value for Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) fell nearly 10 percent Wednesday after the company announced a net loss for the three months that ended in September that was nearly twice as much as analysts expected.
Legacy NID:
128 091